Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Journal of Biological ChemistryOpen Access

Abstract 1187 A novel activity of the RAD52 protein that is essential for the viability of BRCA-deficient breast and ovarian cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlexander V. MazinThe University of Texas Health Science Center at San AntonioMRMatthew J. RossiThe University of Texas Health Science Center at San AntonioOMOlga M. MazinaThe University of Texas Health Science Center at San Antonio

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mazin et al. (2024) studied this question.

synapsesocial.com/papers/68e76a22b6db6435876dfce7https://doi.org/10.1016/j.jbc.2024.106524
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1185 Development of new cancer therapies by targeting the DNA repair protein RAD522024
  2. 2Abstract 2370 RAD52-BRCA synthetic lethality: a search for the critical RAD52 activity2024
  3. 3Unveiling the molecular mechanism of BRCA2-RAD51 interaction to tackle cancer onset2023
  4. 4RAD51 in Breast Cancer: From Vulnerability to Resistance2026
  5. 5RAD51 recombinase: biology, regulation, and therapeutic targeting2026